The battle between GLP-1 receptor agonists (semaglutide) and dual GLP-1/GIP agonists (tirzepatide) is reshaping both diabetes & obesity treatment
To investigate the influence of DPP-4 in the pathogenesis of DSS-induced colitis, DPP-4-deficient mice were used in DSS treatment, and an increase of myeloperoxidase (MPO) activity and expression of NF-B p65 subunit in the colonic tissues was observed
While there is limited research specifically focused on IVF candidates using semaglutide, the general benefits of weight loss and improved blood sugar control could make it a valuable part of a weight management plan
The timing of telogen effluvium is fairly consistent, whether its caused by rapid weight loss, illness, or a major medication change
Patients and healthcare providers need to be aware of how to balance the benefits and risks of each drug
Avoiding these will save you time, money, and frustration